Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00026754 · ClinicalTrials.gov registry record
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 19,522
- Enrollment target
NCT00026754: Completed study, sponsored by National Cancer Institute (NCI).
NCT00026754 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 19,522 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00026754 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 19,522 participants
- Enrollment target
Study Summary
The purpose of this protocol is to provide patients with adequate informed consent to understand that screening tests with minimal health risk will be performed to evaluate their eligibility for a research study. The protocol makes it clear that patients initial visit to the intramural clinical program may include screening studies that are not medically necessary for disease management, but are done purely for research purposes. Patients with a known or suspected diagnosis of cancer, HIV infection, skin disorder or immunodeficiency who are being considered for enrollment in a National Cancer Institute intramural clinical research protocol will participate in this consent protocol. It informs patients of screening tests and procedures involving minimal risk that are done for research purposes only, including blood tests, electrocardiogram, standard X-rays (e.g., chest X-ray), bone films, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine studies. It explains that other eligibility screens that are more invasive and involve greater risk, such as a biopsy, will require separate consent. ...
Primary Outcome
Tissue remaining from collections during the screening process, either for research eligibility or as clinically indicated may be stored for future research
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19,522 participants |
| Start Date | 2004-01-14 |
| Est. Completion | 2024-11-29 |
What the finished NCT00026754 record still lists
NCT00026754 is an observational study that tracks outcomes without assigning an intervention. Its 19,522 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00026754 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00026754 about?
NCT00026754 is a clinical study titled "Eligibility Screening for the NIH Intramural Research Program Clinical Protocols". The purpose of this protocol is to provide patients with adequate informed consent to understand that screening tests with minimal health risk will be performed to evaluate their eligibility for a research study. The protocol makes it clear that patients initial visit to the intramural clinical prog...
What is the current status of trial NCT00026754?
This trial is currently completed. The enrollment target is 19,522 participants. The study started on 2004-01-14. Estimated completion is 2024-11-29.
Who is sponsoring clinical trial NCT00026754?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07152249 · 19,480 participants · NA
Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial
- NCT05555095 · 19,331 participants
Examining Digital Health Care Delivery Models Through Medicaid Collaborative
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI